Cerebral White Matter Disruption in Creutzfeldt-Jakob Disease

References

1. 1.↵
   1. Prusiner SB.

   . Prions. Proc Natl Acad Sci USA 1998;95:13363–83

   CrossRefPubMed
2. 2.↵
   1. Masters CL,
   2. Richardson EP Jr.

   . Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333–44

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Cohen OS,
   2. Hoffmann C,
   3. Lee H,
   4. et al

   . MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease. Cerebellum 2009;8:373–81

   CrossRefPubMed
4. 4.↵
   1. Kallenberg K,
   2. Schulz-Schaeffer WJ,
   3. Jastrow U,
   4. et al

   . Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 2006;27:1459–62

   PubMed
5. 5.↵
   1. Lee H,
   2. Rosenmann H,
   3. Chapman J,
   4. et al

   . Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain 2009;132:2680–87

   CrossRefPubMed
6. 6.↵
   1. Young GS,
   2. Geschwind MD,
   3. Fischbein NJ,
   4. et al

   . Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551–62

   PubMed
7. 7.↵
   1. Manners DN,
   2. Parchi P,
   3. Tonon C,
   4. et al

   . Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology 2009;72:1425–31

   CrossRefPubMed
8. 8.↵
   1. Geschwind MD,
   2. Potter CA,
   3. Sattavat M,
   4. et al

   . Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord 2009;23:82–87

   CrossRefPubMed
9. 9.↵
   1. Fraser H,
   2. Dickinson AG.

   . Targeting of scrapie lesions and spread of agent via the retino-tectal projection. Brain Res 1985;346:32–41

   CrossRefPubMed
10. 10.↵
    1. Taraboulos A,
    2. Jendroska K,
    3. Serban D,
    4. et al

    . Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A 1992;89:7620–24

    CrossRefPubMed
11. 11.↵
    World Health Organization. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: Emerging and Other Communicable Diseases, Surveillance and Control. Geneva, Switzerland: World Health Organization; 1998
12. 12.↵
    1. Skare S,
    2. Andersson JL.

    . On the effects of gating in diffusion imaging of the brain using single shot EPI. Magn Reson Imaging 2001;19:1125–28

    CrossRefPubMed
13. 13.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:S208–19

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Jenkinson M,
    2. Smith S.

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56

    CrossRefPubMed
15. 15.↵
    1. Smith SM.

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Smith SM,
    2. Nichols TE.

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Wakana S,
    2. Caprihan A,
    3. Panzenboeck MM,
    4. et al

    . Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 2007;36:630–44

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Mori S,
    2. Crain BJ

    . MRI Atlas of Human White Matter. Amsterdam, the Netherlands: Elsevier; 2005
20. 20.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR.

    . “Mini-mental state” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Kimberlin RH,
    2. Walker CA.

    . Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol 1979;89:551–62

    CrossRefPubMed
22. 22.↵
    1. Kimberlin RH,
    2. Field HJ,
    3. Walker CA.

    . Pathogenesis of mouse scrapie: evidence for spread of infection from central to peripheral nervous system. J Gen Virol 1983;64:713–16

    CrossRefPubMed
23. 23.↵
    1. Bouzamondo-Bernstein E,
    2. Hopkins SD,
    3. Spilman P,
    4. et al

    . The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 2004;63:882–99

    PubMedWeb of Science
24. 24.↵
    1. Brandner S,
    2. Isenmann S,
    3. Raeber A,
    4. et al

    . Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996;379:339–43

    CrossRef
25. 25.↵
    1. Jendroska K,
    2. Heinzel FP,
    3. Torchia M,
    4. et al

    . Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 1991;41:1482–90

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Safar JG,
    2. Geschwind MD,
    3. Deering C,
    4. et al

    . Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005;102:3501–06

    CrossRefPubMed
27. 27.↵
    1. Prinz M,
    2. Montrasio F,
    3. Furukawa H,
    4. et al

    . Intrinsic resistance of oligodendrocytes to prion infection. J Neurosci 2004;24:5974–81

    CrossRefPubMed
28. 28.↵
    1. Radovanovic I,
    2. Braun N,
    3. Giger OT,
    4. et al

    . Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J Neurosci 2005;25:4879–88

    CrossRefPubMed
29. 29.↵
    1. Nazor KE,
    2. Seward T,
    3. Telling GC.

    . Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim Biophys Acta 2007;1772:645–53

    CrossRefPubMed
30. 30.↵
    1. Liberski PP,
    2. Yanagihara R,
    3. Gibbs CJ,
    4. et al,
    5. et al

    . White matter ultrastructural pathology of experimental Creutzfeldt-Jakob disease in mice. Acta Neuropathol 1989;79:1–9

    CrossRefPubMed
31. 31.↵
    1. Liberski PP,
    2. Yanagihara R,
    3. Gibbs CJ,
    4. et al

    . Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation. Arch Virol 1990;111:141–47

    CrossRefPubMed
32. 32.↵
    1. Liberski PP,
    2. Budka H.

    . Neuroaxonal pathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1999;97:329–34

    CrossRefPubMed
33. 33.↵
    1. Matsusue E,
    2. Kinoshita T,
    3. Sugihara S,
    4. et al

    . White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 2004;25:910–18

    PubMed
34. 34.↵
    1. Armstrong RA.

    . A quantitative study of the pathological changes in the cortical white matter in variant Creutzfeldt-Jakob disease (vCJD). Clin Neuropathol 2010;29:390–96

    PubMed
35. 35.↵
    1. Bell JE,
    2. Ironside JW.

    . Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993;49:738–77

    PubMedWeb of Science
36. 36.↵
    1. Fraser E,
    2. McDonagh AM,
    3. Head M,
    4. et al

    . Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies. Neuropathol Appl Neurobiol 2003;29:482–95

    CrossRefPubMed
37. 37.↵
    1. Cali I,
    2. Castellani R,
    3. Yuan J,
    4. et al

    . Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 2006;129:2266–77

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Beaulieu C.

    . The basis of anisotropic water diffusion in the nervous system—a technical review. NMR Biomed 2002;15:435–55

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Fulbright RK,
    2. Hoffmann C,
    3. Lee H,
    4. et al

    . MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008;29:1638–43

    PubMed
40. 40.↵
    1. Baratti C,
    2. Barnett AS,
    3. Pierpaoli C.

    . Comparative MR imaging study of brain maturation in kittens with T1, T2, and the trace of the diffusion tensor. Radiology 1999;210:133–42

    PubMed
41. 41.↵
    1. Li TQ,
    2. Chen ZG,
    3. Hindmarsh T.

    . Diffusion-weighted MR imaging of acute cerebral ischemia. Acta Radiol 1998;39:460–73

    PubMed
42. 42.↵
    1. Neil JJ,
    2. Shiran SI,
    3. McKinstry RC,
    4. et al

    . Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57–66

    PubMed
43. 43.↵
    1. Seal ML,
    2. Yucel M,
    3. Fornito A,
    4. et al

    . Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity. Schizophr Res 2008;101:106–10

    CrossRefPubMed
44. 44.↵
    1. Zanusso G,
    2. Ferrari S,
    3. Benedetti D,
    4. et al

    . Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease. Ann N Y Acad Sci 2009;1170:637–43

    CrossRefPubMed
45. 45.↵
    1. Kucharczyk W,
    2. Bergeron C.

    . Primary white matter involvement in sporadic-type Creutzfeldt-Jakob disease? Which came first, the chicken or the egg? AJNR Am J Neuroradiol 2004;25:905–06

    PubMed